NO20011576D0 - Farmasöytiske blandinger basert på <alfa>-cyklodekstrin for oral administrasjon av LH-RH analoger - Google Patents

Farmasöytiske blandinger basert på <alfa>-cyklodekstrin for oral administrasjon av LH-RH analoger

Info

Publication number
NO20011576D0
NO20011576D0 NO20011576A NO20011576A NO20011576D0 NO 20011576 D0 NO20011576 D0 NO 20011576D0 NO 20011576 A NO20011576 A NO 20011576A NO 20011576 A NO20011576 A NO 20011576A NO 20011576 D0 NO20011576 D0 NO 20011576D0
Authority
NO
Norway
Prior art keywords
alfa
cyclodextrin
analogs
pharmaceutical compositions
oral administration
Prior art date
Application number
NO20011576A
Other languages
English (en)
Other versions
NO330234B1 (no
NO20011576L (no
Inventor
Remi Delansorne
Paule Bonnet
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of NO20011576L publication Critical patent/NO20011576L/no
Publication of NO20011576D0 publication Critical patent/NO20011576D0/no
Publication of NO330234B1 publication Critical patent/NO330234B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
NO20011576A 1998-09-30 2001-03-28 Anvendelse av <alfa>-cyklodekstrin for fremstilling av en oral sammensetning inneholdende LH-RH-peptidanaloger, samt en oral farmasoytisk sammensetning for administrering av LH-RH-peptidanaloger NO330234B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98402403A EP0998940A1 (en) 1998-09-30 1998-09-30 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
PCT/EP1999/007389 WO2000018423A1 (en) 1998-09-30 1999-09-23 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues

Publications (3)

Publication Number Publication Date
NO20011576L NO20011576L (no) 2001-03-28
NO20011576D0 true NO20011576D0 (no) 2001-03-28
NO330234B1 NO330234B1 (no) 2011-03-07

Family

ID=8235503

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011576A NO330234B1 (no) 1998-09-30 2001-03-28 Anvendelse av <alfa>-cyklodekstrin for fremstilling av en oral sammensetning inneholdende LH-RH-peptidanaloger, samt en oral farmasoytisk sammensetning for administrering av LH-RH-peptidanaloger

Country Status (28)

Country Link
EP (2) EP0998940A1 (no)
JP (1) JP4485060B2 (no)
KR (1) KR100652457B1 (no)
CN (1) CN1200727C (no)
AR (1) AR023056A1 (no)
AT (1) ATE218358T1 (no)
AU (1) AU756233B2 (no)
BR (1) BR9914125A (no)
CA (1) CA2344470C (no)
CZ (1) CZ302343B6 (no)
DE (1) DE69901721T2 (no)
DK (1) DK1117420T3 (no)
EE (1) EE04872B1 (no)
ES (1) ES2178478T3 (no)
HK (1) HK1042047B (no)
HU (1) HUP0103649A3 (no)
ID (1) ID28650A (no)
IL (2) IL142112A0 (no)
MX (1) MXPA01003340A (no)
NO (1) NO330234B1 (no)
NZ (1) NZ510446A (no)
PL (1) PL200693B1 (no)
PT (1) PT1117420E (no)
RU (1) RU2214270C2 (no)
SI (1) SI1117420T1 (no)
TR (1) TR200100887T2 (no)
WO (1) WO2000018423A1 (no)
ZA (1) ZA200102452B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
SE0104462D0 (sv) 2001-12-29 2001-12-29 Carlbiotech Ltd As Peptide purifcation (Peptidrening)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
US4659969A (en) * 1984-08-09 1987-04-21 Synektron Corporation Variable reluctance actuator having position sensing and control
PT88490B (pt) * 1987-09-14 1992-11-30 Novo Nordisk As Processo para a preparacao de composicoes farmaceuticas para libertacao nao-enterica trans-mucosa contendo monossacaridos ou oligossacaridos
SI9300470A (en) * 1993-09-10 1995-04-30 Lek Tovarna Farmacevtskih Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
JPH11292787A (ja) * 1995-08-15 1999-10-26 Asahi Chem Ind Co Ltd 生理活性ペプチドを含有する経粘膜投与製剤
EP0839525B1 (en) * 1996-10-31 2004-08-04 Takeda Chemical Industries, Ltd. Sustained-release preparation
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IL142112A (en) 2006-10-31
ZA200102452B (en) 2002-03-26
DK1117420T3 (da) 2002-09-16
SI1117420T1 (en) 2002-12-31
CZ302343B6 (cs) 2011-03-23
NZ510446A (en) 2003-01-31
NO330234B1 (no) 2011-03-07
AU756233B2 (en) 2003-01-09
HUP0103649A2 (hu) 2002-02-28
ID28650A (id) 2001-06-21
TR200100887T2 (tr) 2001-10-22
CA2344470C (en) 2009-01-06
ES2178478T3 (es) 2002-12-16
MXPA01003340A (es) 2004-04-21
NO20011576L (no) 2001-03-28
HK1042047B (zh) 2005-12-16
WO2000018423A1 (en) 2000-04-06
EP1117420A1 (en) 2001-07-25
AR023056A1 (es) 2002-09-04
HUP0103649A3 (en) 2002-05-28
JP4485060B2 (ja) 2010-06-16
EP0998940A1 (en) 2000-05-10
DE69901721T2 (de) 2003-01-09
BR9914125A (pt) 2001-06-19
IL142112A0 (en) 2002-03-10
ATE218358T1 (de) 2002-06-15
KR20010075255A (ko) 2001-08-09
JP2002525336A (ja) 2002-08-13
EE04872B1 (et) 2007-08-15
KR100652457B1 (ko) 2006-11-30
EE200100196A (et) 2002-06-17
EP1117420B1 (en) 2002-06-05
PL346939A1 (en) 2002-03-11
CN1324241A (zh) 2001-11-28
PT1117420E (pt) 2002-10-31
AU6199999A (en) 2000-04-17
PL200693B1 (pl) 2009-01-30
CA2344470A1 (en) 2000-04-06
DE69901721D1 (de) 2002-07-11
RU2214270C2 (ru) 2003-10-20
CZ20011173A3 (cs) 2001-09-12
CN1200727C (zh) 2005-05-11

Similar Documents

Publication Publication Date Title
NO20004823L (no) Nye galeniske formuleringer av meloksicam for oral administrering
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
PT1043977E (pt) Forma de dosagem farmaceutica oral de libertacao por impulsos
BR9810495A (pt) Composição farmacêutica
NO962490D0 (no) Orale formuleringer av S(+)-ibuprofen
CO5590918A2 (es) Formulaciones
NO20021834D0 (no) Orale formuleringer av anti-tumorforbindelser
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
NO991613L (no) Farmas°ytiske mikrosfµrer av valpronsyre for oral administrering
NO20020176D0 (no) Sykliske peptidderivater som inhibitorer for intergrin &lt;alfa&gt;v&lt;beta&gt;6
NO993927D0 (no) Farmasöytiske blandinger i törr form for oral administrasjon av en syklisk kvaternær ammoniumforbindelse
NO20011576L (no) Farmasöytiske blandinger basert på &lt;alfa&gt;-cyklodekstrin for oral administrasjon av LH-RH analoger
DE69812962D1 (de) Oral anzuwendende Arzneizubereitung enthaltend S-(3-Hydroxypropyl)-L-Cystein
DE69825193D1 (de) Pyridazinon-Verbindungen enthaltenden Zusammensetzungen zur oralen Verabreichung
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
NO20032581D0 (no) Farmasöytisk formulering av gepiron for oral administrering
KR970000226A (ko) S-이부프로펜의 경구용 제형
MA26693A1 (fr) Compositions pour administration par voie buccale
ITMI992202A0 (it) Composizioni farmaceutiche contenenti farmaci antiinfiammatori
AU6349599A (en) Use of xanthan gums for preparing pharmaceutical compositions
EP1133996A4 (en) DRUG COMPOSITIONS WITH PERIODIC ADMINISTRATION
ITMI920214A1 (it) Composizioni farmaceutiche stabili per la somministrazione orale di calcitonina

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees